시장보고서
상품코드
2055291

조영제 시장 : 유형별, 영상 진단법별, 용도별, 투여 경로별, 최종사용자별, 지역별

Contrast Media Market, By Type, By Imaging Technique, By Application, By Route of Administration, By End User, By Geography

발행일: | 리서치사: 구분자 Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
Unprintable PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 4,500 금액 안내 화살표 ₩ 6,988,000
PDF & Excel (Multi User License - Up to 7 Users) help
PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.
US $ 7,000 금액 안내 화살표 ₩ 10,870,000
PDF & Excel (Corporate User License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 10,000 금액 안내 화살표 ₩ 15,529,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

조영제 시장은 2026년 68억 8,000만 달러로 추정되며, 2033년까지 120억 2,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 8.3%를 기록할 전망입니다.

보고서 범위 보고서 상세
기준 연도 : 2025년 2026년 시장 규모 : 68억 8,000만 달러
과거 데이터 기간 : 2020-2024년 예측 기간 : 2026-2033년
예측 기간(2026-2033년) CAGR : 8.30% 2033년 시장 규모 예측 : 120억 2,000만 달러

세계 조영제 시장은 의료 영상 진단 업계 전체에서 중요한 부분을 차지하며, 진단용 영상 검사 중 신체 내부의 구조를 더 잘 볼 수 있도록 설계된 특수 의약품을 포함하고 있습니다. 조영제(조영 물질 또는 조영 색소라고도 함)는 컴퓨터 단층촬영(CT), 자기공명영상(MRI), 초음파 검사, X선 검사 등 다양한 영상 진단 검사를 받는 환자에게 투여되어, 진단 정확도와 임상 결과의 향상에 기여합니다.

이 시장은 요오드계 조영제, 가돌리늄계 조영제, 바륨계 화합물, 마이크로버블 조영제 등 특정 영상 진단 용도나 환자의 요구 사항에 맞추어 설계된 다양한 유형의 조영제로 구성되어 있습니다. 만성 질환 유병률 증가, 고령화 사회의 진전, 그리고 의료용 영상 진단 장비의 기술 발전에 따라, 첨단 조영제 솔루션에 대한 수요는 전 세계적으로 계속 확대되고 있습니다. 이 시장은 부작용을 최소화하면서 진단 정확도를 높여야 할 필요성에 힘입어, 제제 화학, 안전성 프로파일, 그리고 표적 영상 진단 분야에서의 지속적인 혁신이 특징입니다. 주요 시장 진출기업들은 전 세계 다양한 의료 현장에서 진화하는 임상적 요구와 규제 기준을 충족하기 위해, 생체 적합성 향상, 신독성 감소, 그리고 영상 진단 능력 강화를 갖춘 차세대 조영제 개발에 주력하고 있습니다.

시장 역학

세계 조영제 시장의 성장은 주로 몇 가지 주요 요인에 의해 주도되고 있으며, 이러한 요인들이 결합되어 전 세계 의료 시스템 전반에 걸쳐 지속적인 성장 궤도를 뒷받침하고 있습니다. 심혈관 질환, 암, 신경계 질환의 발병률이 증가함에 따라 정밀한 영상 진단 기법이 요구되고 있으며, 그 결과 해부학적 구조와 병세를 정확하게 시각화할 수 있는 고품질 조영제에 대한 수요가 높아지고 있습니다. 고해상도 CT 스캐너, 첨단 MRI 시스템 및 첨단 초음파 장비의 개발을 포함한 의료용 영상 진단 장비의 기술적 진보는 향상된 영상 진단 능력을 활용할 수 있는 개선된 조영제 제제의 개발 기회를 창출하고 있습니다.

세계적인 고령화는 중요한 성장 요인이 되고 있습니다. 고령 환자는 만성 질환 관리나 예방 의료 검진 프로그램을 위해 더 자주 영상 진단을 받아야 하기 때문입니다. 그러나 시장에는 뚜렷한 제약도 존재합니다. 특히, 대규모 임상시험이나 안전성 평가가 필요한 신규 조영제 제제의 경우, 엄격한 규제 승인 절차로 인해 제품 출시가 지연되거나 개발 비용이 증가할 가능성이 있습니다. 특정 조영제와 관련된 조영제 유발성 신증, 알레르기 반응 및 신성 전신성 섬유증에 대한 안전성 우려는 시장 확대에 걸림돌이 되고 있으며, 의료진과 환자들 사이에서 신중한 사용 경향을 초래하고 있습니다. 이러한 제약이 있음에도 불구하고, 개발도상국의 의료 인프라 확충, 의료비 증가, 질병 조기 발견에 대한 인식 제고, 그리고 표적화된 영상 진단 솔루션을 제공하는 장기 특이적 조영제의 개발 등으로 인해 큰 기회가 창출되고 있습니다.

본 조사의 주요 특징

  • 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
  • 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
  • 본 조사에서는 다음의 주요 항목(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)을 바탕으로 전 세계 조영제 시장의 주요 기업 프로파일을 작성하였습니다.
  • 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
  • 본 세계 조영제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자들은 세계 조영제 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.

목차

제1장 조사 목적과 전제조건

제2장 시장 전망

제3장 시장 역학, 규제 및 동향 분석

제4장 세계의 조영제 시장 : 유형별, 2021년-2033년

제5장 세계의 조영제 시장 : 영상 진단법별, 2021년-2033년

제6장 세계의 조영제 시장 : 용도별, 2021년-2033년

제7장 세계의 조영제 시장 : 투여 경로별, 2021년-2033년

제8장 세계의 조영제 시장 : 최종사용자별, 2021년-2033년

제9장 세계의 조영제 시장 : 지역별, 2021년-2033년

제10장 경쟁 구도

제11장 애널리스트의 제안

제12장 참고 문헌 및 조사 방법

LSH

Contrast Media Market is estimated to be valued at USD 6.88 Bn in 2026 and is expected to reach USD 12.02 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.3% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 6.88 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 8.30% 2033 Value Projection: USD 12.02 Bn

The global contrast media market represents a critical segment within the broader medical imaging industry, encompassing specialized pharmaceutical agents designed to enhance the visibility of internal body structures during diagnostic imaging procedures. These contrast agents, also known as contrast materials or contrast dyes, are administered to patients undergoing various imaging modalities including computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and X-ray examinations to improve diagnostic accuracy and clinical outcomes.

The market comprises different types of contrast media, including iodinated contrast agents, gadolinium-based contrast agents, barium-based compounds, and microbubble contrast agents, each tailored for specific imaging applications and patient requirements. With the increasing prevalence of chronic diseases, aging population demographics, and technological advancements in medical imaging equipment, the demand for sophisticated contrast media solutions continues to expand globally. The market is characterized by continuous innovation in formulation chemistry, safety profiles, and targeted imaging applications, driven by the need for enhanced diagnostic precision while minimizing adverse reactions. Key market participants focus on developing next-generation contrast agents with improved biocompatibility, reduced nephrotoxicity, and enhanced imaging capabilities to meet evolving clinical demands and regulatory standards across diverse healthcare settings worldwide.

Market Dynamics

The global contrast media market growth is primarily driven by several key factors that collectively fuel its sustained growth trajectory across international healthcare systems. The increasing incidence of cardiovascular diseases, cancer, and neurological disorders necessitates advanced diagnostic imaging procedures, thereby boosting demand for high-quality contrast agents that enable precise visualization of anatomical structures and pathological conditions. Technological advancements in medical imaging equipment, including the development of high-resolution CT scanners, advanced MRI systems, and sophisticated ultrasound devices, create opportunities for enhanced contrast media formulations that can capitalize on improved imaging capabilities.

The aging global population represents a significant growth driver, as elderly patients require more frequent diagnostic imaging procedures for chronic disease management and preventive healthcare screening programs. However, the market faces notable restraints including stringent regulatory approval processes that can delay product launches and increase development costs, particularly for novel contrast agent formulations requiring extensive clinical trials and safety evaluations. Safety concerns related to contrast-induced nephropathy, allergic reactions, and nephrogenic systemic fibrosis associated with certain contrast agents pose challenges for market expansion, leading to cautious adoption patterns among healthcare providers and patients. Despite these constraints, substantial opportunities emerge from expanding healthcare infrastructure in developing economies, increasing healthcare expenditure, growing awareness about early disease detection, and the development of organ-specific contrast agents that offer targeted imaging solutions.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global contrast media market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include GE Healthcare, Bayer AG, Bracco Imaging, Siemens Healthineers, Fujifilm Holdings Corporation, Philips Healthcare, Guerbet Group, Mallinckrodt Pharmaceuticals, Canon Medical Systems, Hologic, Inc., Lantheus Medical Imaging, COVIDIEN (Medtronic), Esaote S.p.A., Shimadzu Corporation, and Hughes Medical Systems.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global contrast media market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contrast media market.

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Iodinated Contrast Media
  • Monomeric Iodinated Contrast Media
  • Dimeric Iodinated Contrast Media
  • Gadolinium-Based Contrast Media (GBCM)
  • Barium-Based Contrast Media
  • Others (Microbubble Contrast Media)
  • Imaging Technique Insights (Revenue, USD Bn, 2021 - 2033)
  • X-ray/Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound Imaging
  • Fluoroscopy
  • Others (Angiography)
  • Application Insights (Revenue, USD Bn, 2021 - 2033)
  • Cardiovascular
  • Oncology
  • Neurology
  • Gastrointestinal
  • Musculoskeletal
  • Pulmonary
  • Urology
  • Infectious Diseases
  • Other Therapeutic Areas
  • Route Of Administration Insights (Revenue, USD Bn, 2021 - 2033)
  • Oral
  • Rectal
  • Intravenous
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Diagnostic Centers
  • Imaging Centers
  • Ambulatory Surgical Centers
  • Others (Research and Academic Institutes)
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • GE Healthcare
  • Bayer AG
  • Bracco Imaging
  • Siemens Healthineers
  • Fujifilm Holdings Corporation
  • Philips Healthcare
  • Guerbet Group
  • Mallinckrodt Pharmaceuticals
  • Canon Medical Systems
  • Hologic, Inc.
  • Lantheus Medical Imaging
  • COVIDIEN (Medtronic)
  • Esaote S.p.A.
  • Shimadzu Corporation
  • Hughes Medical Systems

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Contrast Media Market, By Type
    • Global Contrast Media Market, By Imaging Technique
    • Global Contrast Media Market, By Application
    • Global Contrast Media Market, By Route of Administration
    • Global Contrast Media Market, By End User
    • Global Contrast Media Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Contrast Media Market, By Type, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Iodinated Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Monomeric Iodinated Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Dimeric Iodinated Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Gadolinium-Based Contrast Media (GBCM)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Barium-Based Contrast Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others (Microbubble Contrast Media)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Contrast Media Market, By Imaging Technique, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • X-ray/Computed Tomography (CT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Magnetic Resonance Imaging (MRI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ultrasound Imaging
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Fluoroscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others (Angiography)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Contrast Media Market, By Application, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Cardiovascular
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Gastrointestinal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Musculoskeletal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Pulmonary
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Urology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Other Therapeutic Areas
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Contrast Media Market, By Route of Administration, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Rectal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Intravenous
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Contrast Media Market, By End User, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Imaging Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  • Others (Research and Academic Institutes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Contrast Media Market, By Region, 2021 - 2033, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Type, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Imaging Technique, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bracco Imaging
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fujifilm Holdings Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Philips Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Guerbet Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mallinckrodt Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Canon Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hologic, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lantheus Medical Imaging
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • COVIDIEN (Medtronic)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Esaote S.p.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Shimadzu Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Hughes Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기